Considerations for master protocols using external controls.
Saved in:
| Title: | Considerations for master protocols using external controls. |
|---|---|
| Authors: | Chen J; Data Sciences, ECR Global, Shanghai, China., Li XN; Global Statistics, BeiGene, San Mateo, California, USA., Lu CC; Oncology Biometrics, AstraZeneca, Boston, Massachusetts, USA., Yuan S; Oncology Statistics, GlaxoSmithKline, Collegeville, Pennsylvania, USA., Yung G; Product Development Data and Statistical Sciences, Genentech/Roche, South San Francisco, Cambridge, USA., Ye J; Global Statistics and Data Sciences, BeiGene, Fulton, Maryland, USA., Tian H; Global Statistics, BeiGene, Ridgefield Park, New Jersy, USA., Lin J; Statistical & Quantitative Sciences, Takeda, Cambridge, Massachusetts, USA. |
| Source: | Journal of biopharmaceutical statistics [J Biopharm Stat] 2025 Mar; Vol. 35 (2), pp. 297-319. Date of Electronic Publication: 2024 Feb 16. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: England NLM ID: 9200436 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-5711 (Electronic) Linking ISSN: 10543406 NLM ISO Abbreviation: J Biopharm Stat Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
